IN8BIO, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IN8BIO, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $11.00K, a 99.70% decline year-over-year.
- IN8BIO, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $1.11M, a 284.78% increase year-over-year.
- IN8BIO, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $3.62M, a 2.52% increase year-over-year.
- IN8BIO, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $3.73M.
- IN8BIO, INC. stock issued during period, value, new issues for fiscal 2025 was $8.57M, a 124.48% increase from fiscal 2024.
- IN8BIO, INC. stock issued during period, value, new issues for fiscal 2024 was $3.82M, a 73.46% decline from fiscal 2023.
- IN8BIO, INC. stock issued during period, value, new issues for fiscal 2023 was $14.38M, a 50.70% increase from fiscal 2022.
- IN8BIO, INC. stock issued during period, value, new issues for fiscal 2022 was $9.54M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $11.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $8.57M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $1.11M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.62M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $3.73M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $3.82M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $289.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $3.53M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $14.38M 10-K · filed 2025-03-13 | |
| 2023-09-30 | $1.89M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $11.71M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $722.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $9.54M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $9.50M 10-Q · filed 2023-11-09 | |
| 2020-03-31 | $200.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |